Prostate Cancer Immunotherapy.  Dr. Neal Shore serves as Medical Director for the Carolina Urologic Research Center and is in practice at the Atlantic Urology Clinics in Myrtle Beach, South Carolina. Dr. Shore has conducted more than 250 clinical trials, focusing mainly on prostate and bladder disease, and serves on the boards of several academic and advocacy networks.  Dr. Shore is questioned by Joel Nowak, MSW, MS, Director, Advocacy and Advanced Stage Disease at Malecare.

For more information about prostate cancer, visit http://malecare.org and http://advancedprostatecancer.net

Dr John Wie from University of Michigan and Joel Nowak from Malecare Cancer Support discuss the PCA3 test.

For more information about prostate cancer, visit http://malecare.org and http://advancedprostatecancer.net

Prostate Cancer testing using genomics.  Dr. Daniel Lieber and Dr. Steve Hershman are interviewed about the latest genomic tests for prostate cancer.  Both Dr. Lieber and Dr. Hershman are PhD graduates of Harvard University System Biology program.  They are interviewed by Joel Nowak,  MSW, Director of Malecare Advanced Disease and Advocacy.
This podcast is presented by Malecare Cancer Support, the worlds leading men's cancer survivor support and advocacy nonprofit organization.  More information can be found at http://malecare.org

Information about Advanced Prostate Cancer can be found at http://advancedprostatecancer.net 

Family history and genetics. Prostate cancer is often referred to as a family disease. Is it and what does this actually mean?

Malecare's Advanced Prostate Cancer Program Director, Joel Nowak, interviews Dr. Lorelei A. Mucci. Dr. Mucci is an epidemiologist specializing in prostate cancer. She works at the Harvard University School of Public Health in Boston, Massachusetts.